/Companies

Alebund

Shanghai, CN · 12 known investors

Find your way into Alebund

Sign up to see every warm intro you have to Alebund

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Alebund team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease. The company operates manufacturing facilities in China and has established commercial networks across major Chinese cities and hospitals.

Investors · 12

Also in the syndicate · 5

HT CapitalLoyal Valley CapitalleadMorningside VenturesleadOctagon CapitalVerition Fund Management

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Alebund do?
An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease. The company operates manufacturing facilities in China and has established commercial networks across major Chinese cities and hospitals.
Who are Alebund's investors?
Alebund's investors include LAV, Lilly Asia Ventures, Quan Capital, 3E Bioventures Capital, 3H Health Investment, Sherpa Healthcare Partners, YuanBio Venture Capital.
Where is Alebund headquartered?
Alebund is headquartered in Shanghai, CN.